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Background: Minor ginsenosides, those having low content in ginseng, have higher pharmacological
activities. To obtain minor ginsenosides, the biotransformation of American ginseng protopanaxadiol
(PPD)-ginsenoside was studied using special ginsenosidase type-I from Aspergillus niger g.848.
Methods: DEAE (diethylaminoethyl)-cellulose and polyacrylamide gel electrophoresis were used in
enzyme puriﬁcation, thin-layer chromatography and high performance liquid chromatography (HPLC)
were used in enzyme hydrolysis and kinetics; crude enzyme was used in minor ginsenoside preparation
from PPD-ginsenoside; the products were separated with silica-gel-column, and recognized by HPLC and
NMR (Nuclear Magnetic Resonance).
Results: The enzyme molecular weight was 75 kDa; the enzyme ﬁrstly hydrolyzed the C-20 position 20-
O-b-D-Glc of ginsenoside Rb1, then the C-3 position 3-O-b-D-Glc with the pathway Rb1/Rd/F2/C-K.
However, the enzyme ﬁrstly hydrolyzed C-3 position 3-O-b-D-Glc of ginsenoside Rb2 and Rc, ﬁnally
hydrolyzed 20-O-L-Ara with the pathway Rb2/C-O/C-Y/C-K, and Rc/C-Mc1/C-Mc/C-K. Ac-
cording to enzyme kinetics, Km and Vmax of MichaeliseMenten equation, the enzyme reaction velocities
on ginsenosides were Rb1 > Rb2 > Rc > Rd. However, the pure enzyme yield was only 3.1%, so crude
enzyme was used for minor ginsenoside preparation. When the crude enzyme was reacted in 3%
American ginseng PPD-ginsenoside (containing Rb1, Rb2, Rc, and Rd) at 45C and pH 5.0 for 18 h, the
main products were minor ginsenosides C-Mc, C-Y, F2, and C-K; average molar yields were 43.7% for C-
Mc from Rc, 42.4% for C-Y from Rb2, and 69.5% for F2 and C-K from Rb1 and Rd.
Conclusion: Four monomer minor ginsenosides were successfully produced (at low-cost) from the PPD-
ginsenosides using crude enzyme.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Ginseng, an important traditional medicinal herb, has been
widely used for thousands of years in Asia, and has been popular-
ized in many Western countries during recent decades. Ginseng
refers to species within the genus Panax (Araliaceae family) that
comprise approximately 14 species of slow-growing perennialalian Polytechnic University, Qing
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ginseng (Korean or Asian ginseng), Panax quinquefolius (American
ginseng), and Panax notoginseng (Notoginseng or Sanchi ginseng)
[1].
The major physiological activity compositions of ginseng are
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namely dammarane- and oleanane-type. The dammarane-type
ginsenosides can be classiﬁed into the protopanaxadiol (PPD)-
type ginsenoside (such as Rb1, Rb2, Rc, and Rd) and
protopanaxatriol-type ginsenoside (such as Re, Rf, and Rg1) [2,3].
So far,>150 naturally occurring ginsenosides have been isolated
from roots, leaves/stems, fruits, and/or ﬂower heads of ginseng [3].
However, >80e90% ginsenosides in Korean ginseng are Rb1, Rb2 ,
Rc, Rd, Re, Rg1, and Rf; >80e90% of ginsenosides in American
ginseng are Rb1, Rb2, Rc, Rd, Re, and Rg1; and >80e90% ginseno-
sides in Notoginseng are ginsenosides Rb1, Rg1, Rd, Re, and R1 [4].
These major ginsenosides have multiple sugar moieties, have
low activities and are hardly absorbed by the human body [5]. After
oral intake of ginseng, the ginsenosides are hydrolyzed by digestive
enzymes and/or intestinal bacteria into minor ginsenosides, which
are absorbed slowly in the gastrointestinal tract to exhibit physio-
logical activity [6]; but, these conversions are low, and the ab-
sorption of major ginsenosides, including Rb1, Rb2 , Rc, Rd, Re and
Rg1, by the gastrointestinal tract is quite poor [7].
The minor ginsenosides, such as F2, Compound-K (C-K),
Compound-C-Mc (C-Mc), Compound-Y (C-Y), Rg3, Rg2, Rh2, Rh1,
and F1, which are present at a low concentration in red ginseng and
wild ginseng, can be produced by hydrolyzing the sugar moieties of
major ginsenosides, including Rb1, Rb2 , Rc, Rd, Rf, Re, and Rg1 [8e
10]. Many studies show that the minor ginsenosides have good
pharmacological activities [11], such as anticarcinogenic [12e14],
immunomodulatory, anti-inﬂammatory, antiallergic [15], anti-
atherosclerotic, antihypertensive, antiaging, and antidiabetic [16]
effects as well as antistress activity and effects on the central ner-
vous system [11,17,18]. Therefore, ginsenoside sugar chains are
closely related to their biological activity, and the modiﬁcation of
their sugar chains may markedly change their pharmacological
activity. The pharmacological activity of ginsenoside increases with
the decrease of the number of the sugar moieties [10,19,20].
To obtain the minor ginsenosides, which have higher pharma-
cological activities, and are easily absorbed by the body, the
methods of microbial or enzymatic transformation, and cloned
ginsenosidase have been reported [10]: for example, ginsenoside Re
can be hydrolyzed into Rg1 and Rh1, and ginsenoside Rb1 can be
hydrolyzed to F2 and C-K by intestinal bacteria [5,6]; cloned gin-
senosidase can convert ginsenoside Rc to C-Mc1 and C-Mc, and
convert ginsenoside Rb2 to C-O and C-Y [21,22], etc.
In our laboratory, four kinds of ginsenosidase, named Type I
[23,24], Type II [25], Type III [22], and Type IV [23], have been
discovered. Ginsenosidase Type I can hydrolyze the 3-O- and 20-O-
glycosides of PPD type ginsenoside; Type II can hydrolyze the 20-O-
glycosides of PPD type ginsenoside; Type III can hydrolyze the 3-O-
glycosides of PPD type ginsenoside; and Type IV can hydrolyze the
6-O- and 20-O-glycosides of protopanaxatriol type ginsenoside
including Re and Rg1 to obtain wide variety of minor ginsenosides.
However, many studies on the preparation of minor ginseno-
sides used the high-cost monomer ginsenosides or high-cost pure
enzyme. It is therefore necessary to produce the minor ginsenoside
C-Y, C-Mc, F2, and C-K from PPD ginsenoside using the crude
enzyme of low cost.
In this paper, a special ginsenosidase type-I from Aspergillus
niger g.848 strain, the enzyme reaction pathway was different from
ginsenosidase type-I from A. niger g.48 strain [24], was puriﬁed and
characterized; and the enzyme reaction kinetics of the ginseno-
sides Rb1, Rb2, Rc, and Rd were studied. In the enzyme puriﬁcation,
the pure enzyme yield was very low, losing >95% enzyme [23e26].
Therefore, to obtain minor ginsenosides at a low cost, the produc-
tion of minor ginsenosides such as C-Mc, C-Y, F2, and C-K was
studied from the American ginseng PPD-ginsenoside containing
Rb1, Rb2, Rc, and Rd using the nonegene-cloning crude enzymefrom A. niger g.848 strain; and the product mixture of minor gin-
senosides C-Mc, C-Y, F2, and C-Kwas separated tomonomers with a
silica-gel column.
2. Materials and methods
2.1. Materials
The standard ginsenosides Rb1, Rb2, Rc, Rd, F2, C-K, C-Mc, C-
Mc1, C-Y, C-O were obtained from Dalian Green Bio Co Ltd, China.
PPD-type ginsenoside of American ginseng was purchased from
Tianle Ltd, Shenyang, China; the weight content ratio of Rb1, Rb2,
Rc, and Rd in PPD-ginsenosides was 39.7% for Rb1, 3.96% for Rb2,
21.3% for Rc, and 35.0% for Rd (i.e., the molar content in 100 g of
PPD-ginsenoside was 35.8 mmol for Rb1, 3.67 mmol for Rb2,
19.7 mmol for Rc, and 37.0 mmol for Rd). The A. niger g.848 strain
obtained from Culture Collection of Biotechnology Engineering of
Dalian Polytechnic University (Dalian, Liaoning Province, P.R.
China) was isolated from traditional Chinese koji (Daqu in Chinese)
[23,25]. Plates of Silica gel (60-F254; Merck, Darmstadt, Germany)
were used for thin-layer chromatography (TLC) analysis. High
performance liquid chromatography (HPLC) grade acetonitrile was
obtained fromMerck. The other chemicals used in this studywere a
minimum of analytical reagent grade. Standard proteins: phos-
phorylase b (97.2 kDa), serum albumin (66.4 kDa), ovalbumin
(44.3 kDa), carbonic anhydrase (29.0 kDa), trypsin inhibitor
(20.1 kDa), and lysozyme (14.3 kDa) were purchased from Takara
Bio Inc, (Japan).
2.2. Enzyme production, puriﬁcation, and molecular weight
The A. niger g.848 strainwas cultured in the medium (200 mL in
1000 mL Erlenmeyer ﬂask) containing 1% ginseng extract and 5%
wheat bran extraction at 30C for 5e6 days. After removing the
cells by centrifugation, the culture was treated with (NH4)2SO4 40%
saturation at 4C for 8 h to remove the protein precipitate by
centrifuging (RCF=22470* g); then (NH4)2SO4 powder was added to
70% saturation and stored at 4C overnight to collect the protein
precipitate by centrifuging; and dialyzed against 0.01M and pH 5.0
acetate buffer, diluted to 1/10 volume of culture with 0.02M and pH
5.0 acetate buffer. Nondissolved material was removed by centri-
fuging to obtain crude enzyme solution.
Enzyme puriﬁcation was carried out by anion exchange chro-
matography and performed using WH-500 USB Protein Chro-
matographic Working Station (HDL UV detector, and BSZ-160
fraction collector; Shanghai Kingdom Biochemical Instrument Co.
Ltd., China). A 10-mL sample of the crude enzyme solution was
eluted on a DEAE-cellulose DE-52 column (4 2.0 cm  10 cm,
Whatman), and the proteins were fractionated stepwise with
0.06M, 0.12M, 0.18M, 0.24M, 0.3M, 0.40M, 0.50M, and 0.60 M KCl in
0.02M acetate buffer (pH 5.0; fraction, 3.0 mL/tube), and the frac-
tions were examined for enzyme activity hydrolyzing ginsenoside
Rb1. The fractions hydrolyzing ginsenoside Rb1 were pooled and
freeze-dried, and dissolved in 1/10 (w/v) distilled water. Then,
further puriﬁcation of the ginsenosidase was carried out using
vertical slab polyacrylamide gel electrophoresis (PAGE) [27]. After
electrophoresis, the enzyme band of the gel was cut, and dissolved
in acetate buffer to remove nondissolved material by centrifugation
to obtain puriﬁed enzyme solution. The purity of enzyme protein
was also examined by the method of HPLC using a TOSOH TSK-Gel-
2000 SW chromatographic column, and by the method of sodium
dodecyl sulfate (SDS)-PAGE. The puriﬁed enzyme solutionwas used
to evaluate the molecular weight and enzyme kinetic parameters.
The molecular weight of the enzyme was determined with SDS-
PAGE [28], using 5% (w/v) stacking polyacrylamide gel and 12% (w/
C.-Y. Liu et al / Minor ginsenoside preparation 223v) separating gel. The calibration curve was done using standard
proteins: lysozyme (14.3 kDa), trypsin inhibitor (20.1 kDa), carbonic
anhydrase (29.0 kDa), ovalbumin (44.3 kDa), serum albumin
(66.4 kDa), and phosphorylase b (97.2 kDa). Protein bands were
visualized with Coomassie brilliant blue R-250. The enzyme protein
concentration with the Folin phenol reagent [29].
2.3. Enzyme analysis and kinetics
A 0.2 mL sample of enzyme from A. niger g.848 strainwas mixed
with the same volume of 25mM Rb1, 25mM Rb2, 25mM Rc, 2.5mM
Rd, and PPD-type ginsenosides (substrate) in 0.02M acetate buffer
(pH 5.0) and allowed to react with shaking at 45C for 3 h (Rb1, Rb2,
andRc) or0.5h (Rd). Thereafter, 0.4mLofwater-saturatedn-butanol
was added to the reaction mixture to stop the enzyme reaction. The
reaction product in the n-butanol layer was analyzed by TLC and
HPLC. A 20-mL sample of crude enzyme was mixed with the same
volume of 6% of PPD-ginsenosides from American ginseng in 0.02M
acetate buffer (pH 5.0; ﬁnal concentration of PPD-ginsenoside, 3%)
and allowed to reactwith shaking at 45C for 12 h,18 h, 24 h, or 30 h.
Then the 0.2 mL of reaction mixture was extracted with 0.4 mL of
water-saturatedn-butanol, and analyzedbyTLCandHPLC. The spots
on the silica plate were scanned using a Shimadzu CS-930 spectro-
photometer (Shimadzu Corp., Kyoto, Japan).
One unit of enzyme activity was deﬁned as the amount of
enzyme that hydrolyzed 1mM of the Rb1 substrate/h in the optimal
enzyme reaction condition [24,26].
In determinationof enzymekinetics: the values of theMichaelise
Menten equation constant (Km) and the maximal reaction velocity
(Vmax) for ginsenosidase type-I were determined by incubating in
0.02Macetate buffer (pH 5.0) at 45Cwith ginsenoside Rb1, Rb2, and
Rc at concentrations of 14.3mM, 16.7mM, 20.0mM, 25.0mM,
33.0mM, and 50.0mM (ﬁnal concentration in reaction: 7.15mM,
8.35mM,10mM,12.5mM,16.5mM,and25mM,respectively), reacting
for 5 min, 10 min, 20 min, 40 min, 60 min, 90 min, 120 min, and
180 min; with Rd at 0.83mM, 1.00mM, 1.25mM, 1.67mM, 2.50mM,
and 5.00mM (ﬁnal concentration: 0.42mM, 0.50mM, 0.63mM,
0.84mM, 1.25mM, and 2.5mM), reacting for 5 min, 10 min, 20 min,
40 min, 60 min, 90 min, 120 min, and 180 min. The reaction results
were determined by TLC. The conversion of TLC was obtained using
Bandscan software (Glyko Inc.,1998) to analyze the area and shadeof
the plots on the TLC silica gel [26]. Values for Km and Vmax were
calculated from LineweavereBurk plots [30]. The transformation
velocity of the hydrolysis on the PPD type ginsenosides was calcu-
lated from the MichaeliseMenten equation [28].
2.4. TLC and HPLC analysis
TLC was carried out using a silica gel G 60 F254 plate (Merck)
with developing solvent consisting of chloroform, methanol, and
water [7:2.5:0.5 (v/v/v)] (under layer), and the produced ginseno-
sides on the silica gel plate were determined by scanning the TLC
spots using a Shimadzu CS-930 [22,26].
The ginsenoside products from the enzyme reaction and
enzyme protein purity were both examined by HPLC (Waters 2695
Separations Module with Waters 2996 Photodiode Array Detector,
Waters Corp., Milford, USA.). A Knauer C-18 chromatographic col-
umn (5 mm, 4 3mm 300mm, Knauer Corp., Berlin, Germany) was
used to analyze the enzymatic reaction products. The mobile phase
was A (acetonitrile) and B (water): 0e20 min, 20% A; 20e31 min, A
from 20% to 32%; 31e40 min, A from 32% to 43%; and 40e70 min, A
from 43% to 100%. The detection wavelength, 203 nm; injected
volume, 10 mL; ﬂow rate, 0.6 mL/min; and column temperature,
35C. All reagent used in HPLC were Chromatographic grade, and
produced from Merck, USA.The sample used for the HPLC was prepared as follows: 1e2 mL
enzymatic reaction mixture was eluted on 10 mL column of AB-8
Diaion resin column (from Tianjin Chemical Plant of Nankai Uni-
versity, P. R. China). The resin column was ﬁrst washed with 80 mL
of a 0.2M phosphate buffer (pH 6.0) and 50 mL of 20% alcohol, and
then eluted with 60 mL of 83% alcohol to separate and collect the
reaction products. These products were dried by vacuum distilla-
tion, and dissolved in 1 mL of methanol prior to the HPLC analysis.
A TOSOH TSK-Gel-2000 SW chromatographic column (4
7.8 mm  300 mm, TOSOH ASA Corp., Yamaguchi, Japan) was used
in the determination of the enzyme purity. The mobile phase was
0.02M pH 6.7 phosphate buffer containing 0.05% sodium azide;
measuring wavelength was 280 nm; the injected volume was
100 mL; and ﬂow rate, 1.0 mL/min.2.5. Preparation of minor ginsenoside C-Mc, C-Y, F2, and C-K from
American ginseng PPD ginsenosides using crude enzyme
The effects of PPD-ginsenoside substrate concentration, pH and
temperature on crude enzyme reaction were examined with the
ginsenoside Rb1 instead of PPD ginsenoisde, and the Rb1 decre-
ment was determined. The substrate concentration (Rb1) was ﬁxed
to 2%, 4%, 6%, 8%, and 10%; the pH was ﬁxed to 2.0, 3.0, 4.0, 5.0, 6.0,
7.0, 8.0, 9.0, and 10.0; the temperature was ﬁxed to 20C, 25C,
30C, 35C, 40C, 45C, 50C, 55C, 60C, 65C, and 70C in the 3%
substrate in reaction.
In the preparation of minor ginsenoside C-Mc, C-Y, F2, and C-K
from American ginseng PPD ginsenosides, the substrate of 6% PPD
ginsenoside in 0.02M and pH 5.0 acetate buffer was reacted with
the same volume of crude enzyme from A. niger g.848 strain in the
Bioreactor (RAT-5D, Shanghai Shenshun Ltd, China). The reaction
was stopped by addition of 95% alcohol (3 volume of reaction
solution), centrifuged, and the supernatant was concentrated by
vacuum distillation to 10% of the original volume to obtain the
reaction products solution containing C-Mc, C-Y, F2, and C-K. The
reaction mixture was eluted on the AB-8 macroporous resin col-
umn (the volume was 20 dried ginsenoside weight) to absorb
ginsenoside, the remove impurities of sugar with water, the volume
of which was 5 that of the column; then the column was eluted
with 4e5 the column volume of 80e84% alcohol; the alcohol
solutionwas eluted on the anion exchange resin D280 (volumewas
same with AB-8 column) for discoloration; the discolored solution
was concentrated and dried by vacuum distillation to get the
product containing minor ginsenoside C-Mc, C-Y, F2, and C-K.
The enzyme reaction products were puriﬁed using a silica gel
column. The products from the enzyme reaction for the puriﬁcation
were ﬁrstly pretreated by dissolving in methanol and chloroform,
and mixed with the 80e100 mesh silica gels, which was 2.3 the
sample weight; then the mixture was dried in a constant temper-
ature bath and stirred constantly to form powder; and the mixture
powder was put in a column (diameter: height ¼ 1:15e20) con-
taining 20 of sample weight for the 300e400 mesh sampleesil-
ica-gel; 2 cm cotton was put on top of the column. The columnwas
ﬁrstly dredged by 100% chloroform, and then eluted with a solvent
consisting of chloroform and methanol [9.5:0.5 (v/v)], the fractions
were 80e300 mL. According to TLC of the fraction, the products
with the same component were then collected and dried by vac-
uum distillation.2.6. NMR analysis
The structures of enzymolysis products C-Mc, C-Y, C-K, and F2
from PPD-type ginsenosides were analyzed using NMR. The prod-
ucts were dissolved in pyridine-d5, and the NMR spectra were
J Ginseng Res 2015;39:221e229224recorded by using the Bruke Avance 600 (1H: 600 MHz; 13C: 150
MHz) NMR spectrometer (Switzerland).Fig. 2. The hydrolysis of the pure enzyme from the Aspergillus niger g.848 strain on the
monoginsenoside Rb1, Rb2, Rc, and Rd. Rb1, Rb2, Rc, Rd, F2, C-K, C-Y, and C-O, C-Mc,
and C-Mc1, standard ginsenosides. 1e3, enzyme reaction product from 25mM Rb1,
25mM Rb2, 25mM Rc reacted at 45C for 3 h; 4, enzyme reaction product from 2.5mM
Rd. Solvent, chloroform:methanol:water ¼ 7.5:2.5:0.5; 10% H2SO4 as a chromogenic
agent.3. Results and discussion
3.1. Enzyme fermentation, puriﬁcation and characterization
The A. niger g.848 strain was cultured in medium (200 mL in
1000 mL Erlenmeyer ﬂask) containing 1% ginseng extract and 5%
wheat bran extract; the best enzyme production was obtained
with 30C culturing for 120 h. The cell-free culture from A. niger
g.848 strain was removed the precipitate by (NH4)2SO4 (40%
saturation); and when (NH4)2SO4 concentration reached 70%
saturation, most ginsenosidase type-I was precipitated. Then, the
protein precipitate collected by centrifuging was dissolved and
dialyzed at to obtain 1/10 volume of the culture, i.e., crude
enzyme. The 10 mL of crude enzyme was eluted on a DEAE-
Cellulose DE-52, and then fractionated stepwise with respec-
tively 50 mL of 0.06M, 0.12M, 0.18M, 0.24M, 0.30M, 0.40M, 0.50M,
and 0.60M KCl in 0.02M and pH 5.0 acetic buffer. The enzyme
activities of the fractions were examined: the 32e36 fractions
eluted by 0.12M and 0.18M KCl solution hydrolyzed the 20mM
ginsenoside Rb1; and the 34 and 35 fractions enzyme activity
exhibited the highest enzyme activity of hydrolyzing ginsenoside
Rb1 and almost single band in the PAGE.
In order to be prudent, vertical slab SDS-PAGE was used for
further puriﬁcation of special ginsenosidase type-I. The result of
SDS-PAGE examination is shown in Fig. 1A: the enzyme represents
a single band on the gel. By calculating the mobility, the molecular
weight (MW) of the ginsenosidase type-I was approximately
75 kDa, which was similar with the MW 80 kDa of ginsenosidase
type-I from Aspergillus sp.g48p strain [23], and the MW 74 kDa of
ginsenosidase type-I from A. niger g.48 strain [24]. The purity of the
puriﬁed ginsenosidase type-I was examined by HPLC (Fig. 1B). Only
one peak was shown on the HPLC spectrum at 6.002 min. All these
results indicated that the ginsenosidase type-I was pure enzyme,
and it was further used to evaluate the enzyme reaction velocity
and kinetic parameters hydrolyzing the different glycosides of the
PPD type ginsenosides.
The optimum temperature of ginsenosidase type-I from A. niger
g.848 strain was 45C, and the optimum pH was 5.0 (data notA                     B 
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Fig. 1. Puriﬁed ginsenosidase Type-I in SDS-PAGE and HPLC. (A) Ginsenosidase Type-I SDS-
ovalbumin (44.3 kDa), carbonic anhydrase (29.0 kDa), trypsin inhibitor (20.1 kDa), and lys
performance liquid chromatography; PAGE, polyacrylamide gel electrophoresis; SDS, sodiushown). In the puriﬁcation, the yield of the ginsenosidase was
about 3.1%, and the speciﬁc activity of the enzyme increased 13
times (data not shown).
3.2. Pure enzyme hydrolysis of the monomer ginsenosides Rb1, Rb2,
Rc, and Rd
The enzyme from the A. niger g.848 strain reacted with 25mM
monomer ginsenoside Rb1, Rb2 and Rc at 45C for 3 h, respectively;
and reacted with 2.5mM Rd at 45C for 0.5 h. The enzyme reaction
products were examined by TLC (Fig. 2).
As shown in Fig. 2, the ginsenosidase produced by A. niger g.848
strain ﬁrstly hydrolyzed the 20-O-b-D-(1/6)-glucopyranoside of
Rb1 into Rd, then hydrolyzed the 3-O-b-D-(1/2)-glucopyranoside
of Rd to F2, further to C-K. However, the enzyme ﬁrstly hydrolyzed
the 3-O-b-D-(1/2)-glucopyranoside of Rb2 into C-O, hydrolyzed
3-O-b-D-glucopyranoside of C-O into C-Y, further hydrolyzed theMinutes
.00 6.00 8.00 10.00 12.00 14.00
6.002
PAGE; marker, marker protein: phosphorylase b (97.2 kDa), serum albumin (66.4 kDa),
ozyme (14.3 kDa). Protein quantity, 3 mg. (B) Ginsenosidase Type-I HPLC. HPLC, high
m dodecyl sulfate.
C.-Y. Liu et al / Minor ginsenoside preparation 22520-O-a-L-(1/6)-arabinopyranoside (arap) of C-Y into C-K; the
enzyme also ﬁrstly hydrolyzed the 3-O-b-D-(1/2)-glucopyrano-
side of Rc to C-Mc1, hydrolyzed the 3-O-b-D-glucopyranoside of C-
Mc1 into C-Mc, and further hydrolyzed 20-O-a-L-(1/6)-arabino-
furanoside (araf) of C-Mc into C-K. The biotransformation pathway
of the ginsenosidase produced by A. niger g.848 strain is shown in
Fig. 3.
Therefore, the enzyme from A. niger g.848 strain can hydrolyze
the 3-C position (3-O-) and 20-C-position (20-O-) multiglycoside of
PPD-type ginsenosides such as Rb1, Rb2, Rc, and Rd, and should be
classiﬁed to ginsenosidase type-I produced by Aspergillus sp.48
strain [23] and A. niger g.48 strain [24]. However, the hydrolysis
pathwayof the special ginsenosidase type-I fromA. niger g.848 strain
in present study is different with that of ginsenosidase type-I from
A. niger g.48 strain; the ginsenosidase type-I (molecular weight,
75 kDa) hydrolysis pathway fromA. niger g.848 strain on ginsenoside
Rb1 (in this study) is Rb1/Rd/F2/C-K; but the ginsenosidase
type-I (molecular weight, 74 kDa) from A. niger g.48 strain hydro-
lyzes both 3-O- and 20-O-glucosides of Rb1 with two pathways: i.e.,
one pathway was Rb1/Rd/F2/C-K; another,
Rb1/Gyp17/Gyp75/C-K [24]. Thus, the enzyme A. niger g.848
strain is a special ginsenosidase type-I differentiating with the gin-
senosidase type-I from A. niger g.48 strain. The ginsenosidase type-I
from A. niger g.848 strain is are suitable than that of A. niger g.48
strain, because the ginsenoside Rb1 is hydrolyzed by ginsenosidase
type-I from A. niger g.848 strain with one pathway, and the enzyme
from A. niger g.48 strain hydrolyzes Rb1 with two pathways [24].Glc¡ª Glc¡ª O
Glc¡ª O
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Fig. 3. Biotransformation pathway of ginsenosides Rb1, Rb23.3. Enzyme reaction kinetics
To determine the enzyme kinetic parameters for Rb1, the
enzyme was reacted with Rb1 at different substrate concentrations
(7.15mM, 8.35mM, 10.0mM, 12.5mM, 16.5mM, 25.0 mM) for 5 min,
10 min, 20 min, 40 min, 60 min, 90 min, 120 min, and 180 min at
45C. The Bandscan software method [26] was used to determine
the conversion rate of Rb1 (the substrate) from the TLC reaction
results (the TLC is omitted). The Rb1 conversion or reduction can be
identiﬁed as the amount of production of Rd and F2.
To examine the more true velocity data, the enzyme reaction
velocity (V) was calculated from the amount of conversion of the
substrate Rb1 using average data of triplicate measurements in the
initial reaction time of 5e10 min; the average velocity (V) values of
ginsenosidase type I in the hydrolysis for the concentrations
7.15mM, 8.35mM, 10mM, 12.5mM, 16.5mM, and 25mM of ginse-
noside Rb1 to Rd were 25.3mM/h, 26.2mM/h, 30.0mM/h, 32,6mM/
h, 40.9mM/h, and 49.7mM/h respectively. Using the Lineweavere
Burk plot of 1/V vs 1/[S] [30], the kinetic parameters of the ginse-
nosidase type I hydrolysis of the 20-O-Glc of ginsenoside Rb1/Rd
in MichaeliseMenten equation were Km ¼ 16.6  1.6mM and
Vmax ¼ 79.6  7.5mM/h. Using the same method as Rb1, the kinetic
parameters of ginsenosidase type I for the ginsenosides Rb2 and Rc
were estimated at the substrate concentrations of 7.15mM,
8.35mM, 10mM, 12.5mM, 16.5mM, and 25mM, the enzyme kinetic
parameters for the hydrolysis of 3-O-Glc of ginsenosides Rb2 were
Km ¼ 20.4  2.1mM and Vmax ¼ 45.6  4.6mM/h; the enzymeGlc¡ª O
Glc¡ª O
HO
HO
Glc¡ª O
HO
C-K
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Fig. 4. Crude enzyme hydrolysis on the PPD ginsenoside for different reaction time.
Rb1, Rd, F2, C-K, standard ginsenosides. PPD, substrate of PPD-ginsenoside. C-Mc and
C-Y were recognized with the standard C-Mc and C-Y. The 6% of PPD-ginsenoside with
the same volume of enzyme (ﬁnal 3% substrate of PPD-ginsenoside) was reacted at
45C for 12 h, 18 h, 24 h, and 30 h; Sample 1 reacted for 12 h; Sample 2 reacted for
18 h; Sample 3 reacted for 24 h; and Sample 4 reacted for 30 h. Solvent,
chloroform:methanol:water ¼ 7.5:2.5:0.5 (v/v/v); 10% H2SO4 as a chromogenic agent.
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were Km ¼ 5.46  0.5mM and Vmax ¼ 6.16  0.6mM/h; the kinetic
parameters for hydrolysis of 3-O-Glc of Rd at the substrate con-
centrations of 0.42mM, 0.50mM, 0.63mM, 0.84mM, 1.25mM, and
2.5mM were Km ¼ 0.603  0.04mM and Vmax ¼ 1.19  0.11mM/h.
The above results used average data of triplicate measurements in
the initial reaction time of 5e10 min (Table 1).
The larger the Km value, the slower the hydrolysis velocity, and
the larger the Vmax value, the faster the hydrolysis velocity. The
above Km and Vmax values of the enzyme reaction (Table 1) cannot
fully represent the enzyme reaction velocities. Therefore, using the
MichaeliseMenten equation [28], the enzyme reaction velocities
for the different ginsenosides (10mM)were calculated. The enzyme
velocities were 29.9mM/h for Rb1,15.0mM/h for Rb2, 3.98mM/h for
Rc, and 1.12mM/h for Rd. According to V0 values in 10mM substrate
(Table 1), the ginsenosidase type-I reaction velocities were 20-O-
Glc of Rb1 > 3-O-Glc of Rb2 > 3-O-Glc of Rc > 3-O-Glc of Rd.
According to the above results, the minor ginsenosides C-Y, C-
Mc, F2, and C-K, which have low sugar-moieties can be prepared
from themonomer ginsenosides Rb2, Rc, Rb1, and Rd by controlling
enzyme reaction conditions such as substrate concentration and
reaction time.
However, the pure ginsenosidase type-I yield was only about
3.1% to lose over 95% enzyme in the enzyme puriﬁcation [23,24,26],
and the cost of monomer ginsenoside Rb1, Rb2, Rc, and Rd was
higher. Therefore, it is necessary to produce the minor ginsenoside
C-Y, C-Mc, F2, and C-K from PPD ginsenoside using the low-cost
crude enzyme.
3.4. Crude enzyme hydrolysis on PPD-ginsenoside containing Rb1,
Rb2, Rc, and Rd
To obtain the minor ginsenosides C-Y, C-Mc, F2, and C-K at low
cost, the PPD-ginsenosides containing Rb1, Rb2, Rc, and Rd from
American ginseng were reacted with the nonegene-cloning crude
enzyme from A. niger g.848 strain; the nonegene-cloning enzyme
using for ginseng products is more welcome for consumers.
When the crude enzyme from the A. niger g.848 strain was
reactedwithmonomer ginsenoside Rb1, Rb2, Rc, and Rd, the results
are similar to that of pure enzyme. When the crude enzyme was
reacted the mixture of PPD-ginsenosides containing Rb1, Rb2, Rc,
and Rd (weight content ratio was about 39.7% for Rb1, 3.96% for
Rb2, 21.3% for Rc, and 35.0% for Rd; i.e., themolar content in 100 g of
PPD-ginsenoside was 35.8 mmol for Rb1, 3.67 mmol for Rb2,
19.7 mmol for Rc, and 37.0 mmol for Rd); the main products were
minor ginsenoside C-Y, C-Mc, F2, and C-K. In optimizing the crude
enzyme reaction for the PPD ginsenoside, the effects of PPD-
ginsenoside substrate concentration, pH, and temperature on
crude enzyme reaction were examined with ginsenoside Rb1
instead of PPD-ginsenoside; good enzyme reactionwas observed in
the 3% of PPD-ginsenoside at 45C and pH 5.0.Table 1
Kinetic parameters of ginsenosidase type-I
Substrate Pathway Km
(mM)
Vmax
(mM/h)
V0
1)
(mM/h)
Rb1 Hydrolysis of 20-O-Glc of
Rb1 to Rd
16.6  1.6 79.6  7.5 29.9
Rb2 Hydrolysis of 3-O-Glc of
Rb2 to C-O
20.4  2.1 45.6  4.6 15.0
Rc Hydrolysis of 3-O-Glc of
Rc to C-Mc1
5.46  0.5 6.16  0.6 3.98
Rd Hydrolysis of 3-O-Glc of
Rd to F2
0.603  0.04 1.19  0.11 1.12
1) Velocities (V0), in 10mM substrate; using average data of triplicate measure-
ments in the initial reaction time of 5e10 min.To obtain good enzyme reaction time, the 20 mL 6% PPD-
ginsenoside was reacted with the same volume of the crude
enzyme solution from A. niger g.848 strain (ﬁnal 3% PPD-
ginsenoside) at 45C and pH 5.0 reacted for 12 h, 18 h, 24 h, and
30 h; the reaction products are shown in Fig. 4.
Fig. 4 shows that, when the crude enzyme reacted with 6% PPD-
ginsenoside (actual substrate concentrationwas 3%) at 45C and pH
5.0 for 12 h, the transformation of ginsenoside Rd in PPD was not
complete; when reacted for 18 h, the main enzyme reaction
products were C-K, C-Mc, C-Y, and F2, and the substrate PPD was
almost completely converted; when reacted over 24 h, the main
enzyme reaction product was C-K. Thus, the good enzyme reaction
time to obtain minor ginsenoside C-K, C-Mc, C-Y, and F2 was 18 h.
Therefore, when producing the minor ginsenoside C-K, C-Mc, C-
Y, and F2 from PPD-ginsenoside of American ginseng, the good
reaction conditions were as the enzymewas reacted at 45C and pH
5.0 for 18 h in 3% substrate concentration of PPD-ginsenoside.
3.5. Preparation and separation of minor ginsenosides C-Mc, C-Y,
F2, and C-K from PPD-ginsenosides
The mixture of minor ginsenosides C-Mc, C-Y, F2, and C-K was
produced from the PPD type ginsenoside using the crude enzyme
from A. niger g.848 strain. Under the above optimal reaction con-
dition, the 80 g PPD ginsenosides were dissolved in 1300 mL of pH
5.0, 0.02M acetate buffer, and mixed with same volume of crude
enzyme, reacted at 45C for 18 h (ﬁnal substrate concentration of
PPD-ginsenoside in reaction solution was 3%); then the 3 volume
of 95% alcohol was added to the reaction mixture to stop the
enzyme reaction, stored overnight to precipitate enzyme protein,
centrifuged to get supernatant, the supernatant was vacuum
concentrated to 10% times of its original volume; then the product
mixture was adsorbed on 1.5 L AB-8 resin column, eluted by water
(5 volume of the column) to remove soluble impurity such as
sugar; then the columnwas elutedwith 5 volume 70e84% alcohol
to elute minor ginsenoside from reaction; the eluted solution was
discolored by 1.5 L column of D-280 resin, vacuum concentrated,
dried to get 50 g of minor ginsenoside mixture; the weight yield
was about 62%. With the same method, the 150 g mixture of minor
ginsenosides was obtained for using in the next experiments.
Table 2
Separation of 5 gmixture of minor ginsenosides obtaining from 8 g PPD-ginsenoside
of American ginseng with a silica gel column 4 25 mm  400 mm. fractions, 80 mL
Dried
sample No.
Fractions Puriﬁed
ginsenosides
Weight
yield (g)
Molar
yield (%)
1 1e2 Impurity 0.03 e
2 3e4 C-K 1.65 69.5 on C-K and F2
3 5 C-K mixture 0.31 e
4 6 Single sport,
but impurity
0.12 e
5 7 C-Mc 0.50 43.7
6 8 Mixture of C-Mc
and C-Y
0. 15 e
7 9 C-Y 0.09 42.4
8 10 Mixture of C-Y
and F2
0. 12 e
9 11e21 F2 1.60 69.5 on C-K and F2
10 22e30 Impurity 0.42 e
e, not determined.
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product from 8 g of PPD-ginsenoside), was separated using a silica-
gel column (4 25 mm  400 mm). The columnwas eluted with the
solution mixing with the solvent consisting of chloroform and
methanol [95:0.5 (v/v)], the fractions were 80 mL. The fraction
ginsenosides were checked by TLC; the fractions of same ginseno-
side were concentrated by vacuum, dried to get single ginsenosides
such as F2, C-Mc, C-Y, and C-K as shown in Table 2 and Fig. 5A.
Table 2 and Fig. 5A show that the separated pure Sample 2 is
1.65 g of C-K; Sample 5 is 0.50 g of C-Mc; Sample 7 is 0.09 g of C-Y;
and Sample 9 is 1.60 g of F2 from 5 g product produced from 8 g
PPD-ginsenoside by enzyme reaction. The purity of minor ginse-
nosides is 95% for C-K, 94% for C-Mc, 90% for C-Y, and 90% for F2
(Fig. 5B).
The 50  2.0 g mixture of minor ginsenoside F2, C-Mc, C-Y, and
C-K were produced from 80 g PPD-ginenoside from American
ginseng, and was separated using the silica-gel column to obtain
the monomer ginsenoside about 5.20  0.50 g of C-Mc,
0.96  0.17 g of C-Y, 16.3  1.5 g of F2, and 16.9  1.3 g of C-K (the
result is the average data of 3 experiments). The minor ginsenoside
C-Mc was only produced from Rc, so the theoretical yield (molar
yield) of C-Mcwas about 43.7%. C-Ywas only produced fromRb2, so
the molar yield of C-Y was about 42.4%. However, the minor gin-
senoside F2 can be produced from ginsenoside Rb1 and Rd; the C-K
can be produced from the ginsenoside Rb1, Rd, Rb2, and Rc;
therefore, to obtain the calculation of theoretical yield of F2 and C-A  
40.00 42
Fig. 5. The separated minor ginsenoside products of Table I with the silica gel column in the
product from PPD substrate by the enzyme. Sample 1, product from fractions 1 and 2; Sam
Sample 5, C-Mc from fraction 7; Sample 6, from fraction 8; Sample 7, C-Y from fractio
chloroform:methanol:water ¼ 7.5:2.5:0.5; 10% H2SO4 as a chromogenic agent. (B) HPLC: T
Retention time: 45.228 min for Sample 9 (F2); 49.092 min for Sample 5 (C-Mc); 59.395 m
chromatography.K, all the ginsenoside Rb1, Rd, Rb2, and Rc in the substrate must be
considered. The molar yield of minor ginsenosides was approxi-
mately 43.7% for C-Mc from Rc, 42.4% for C-Y from Rb2, and rough
estimate 69.5% for F2 and C-K from Rb1 and Rd (ignoring C-K from
the Rb2 and Rc).
In the above experiment, four kinds of monomer ginsenoside
were successfully produced from the low-cost PPD-ginsenosides
containing ginsenoside Rb1, Rb2, Rc, and Rd using the low-cost
crude enzyme from A. niger g.848 strain.
3.6. Structure of the reaction product C-Mc, C-Y, F2, and C-K by
NMR
NMR was used to determine the structure of the enzyme reac-
tion products. The 13C NMR (600 MHz, pyridine-d5) spectral data of
minor ginsenoside products are shown in Table 3. These data
correspond with previous report [31], and the enzyme reaction
products were determined to be minor ginsenosides F2, C-Mc, C-Y,
and C-K, as shown in Table 3.
According to Table 3, the structures of minor ginsenosides
should be F2, C-Mc, C-Y, and C-K as shown in Fig. 6.
In conclusion, four kinds of minor ginsenoside C-Mc, C-Y, F2, and
C-K were produced from PPD-ginsenoside containing ginsenoside
Rb1, Rb2, Rc, and Rd of American ginseng using a special ginseno-
sidase type-I from A. niger g.848 strain. The pure enzymemolecular
weight is about 75 kDa, and ﬁrstly hydrolyzed the C-20 position 20-
O-b-D-Glc of ginsenoside Rb1, then hydrolyzed C-3 position 3-O-b-
D-Glc with the pathway Rb1/Rd/F2/C-K. However, the
enzyme ﬁrstly hydrolyzed C-3 position 3-O-b-D-Glc of ginsenoside
Rb2 and Rc, ﬁnally hydrolyzed 20-O-L-Ara with the pathway
Rb2/C-O/C-Y/C-K and Rc/C-Mc1/C-Mc/C-K. The enzyme
kinetic parameters were Km ¼ 16.6  1.6mM and
Vmax ¼ 79.6  7.5mM/h for Rb1; Km ¼ 20.4  2.1mM and
Vmax ¼ 45.6  4.6mM/h for Rb2; Km ¼ 5.46  0.5mM and
Vmax ¼ 6.16  0.6mM/h for Rc; and Km ¼ 0.603  0.04mM and
Vmax ¼ 1.19  0.11mM/h for Rd; reaction velocities on ginsenosides
were Rb1 > Rb2 > Rc > Rd. However, the pure enzyme yield was
only 3.1%, a loss of >95%, so crude enzyme was used for minor
ginsenoside preparation. The crude enzyme hydrolysis pathways
on Rb1, Rb2, Rc, and Rd were the same as that of pure enzyme.
When the crude enzyme reacted in 3% American ginseng PPD-
ginsenoside at 45C and pH 5.0 for 18 h, the main products were
minor ginsenosides C-Mc, C-Y, F2, and C-K. The 150 g mixture of
minor ginsenoside producing from 240 g PPD ginsenoside wasB
Minutes
.00 44.00 46.00 48.00 50.00 52.00 54.00 56.00 58.00
Sample 9 
F2 
Sample 5 
C-Mc Sample 7 
C-Y 
Sample 2 
C-K 
TLC and HPLC. (A) TLC: F2, C-K, C-Mc, C-Y, standard ginsenosides. P, minor ginsenoside
ple 2, C-K from fractions 3e4; Sample 3, from fraction 5; Sample 4, from fraction 6;
n 9; Sample 8, from fraction 10; and Sample 9, F2 from fractions 10e20. Solvent,
he pure Samples 9, 7, 5, and 2 of minor ginsenosides from enzyme reaction in HPLC.
in for Sample 7 (C-Y); 54.079 min for Sample 2 (C-K). HPLC, high performance liquid
Table 3
The 13C NMR spectroscopic data of enzyme reaction products F2, C-Mc, C-Y, and C-K1)
Carbon site F2 C-Mc C-Y C-K Carbon site F2 C-Mc C-Y C-K
Aglycone moiety 3-O-Glc
C-1 23.39 39.60 39.75 39.72 C-10 107.10 e e e
C-2 26.93 28.41 28.40 28.41 C-20 75.93 e e e
C-3 88.98 79.40 79.45 79.43 C-30 79.43 e e e
C-4 39.37 39.75 39.61 39.58 C-40 71.80 e e e
C-5 56.56 56.57 56.58 56.53 C-50 78.50 e e e
C-6 18.63 18.97 18.97 18.93 C-60 63.26 e e e
C-7 35.30 35.37 35.38 35.34 20-O-Glc
C-8 40.22 40..26 40.27 40.24 C-10 98.42 98.25 98.25 98.40
C-9 50.37 50.49 50.52 50.47 C-20 75.28 75.19 75.03 75.27
C-10 37.13 37.55 37.55 37.52 C-30 78.90 78.29 78.29 78.40
C-11 31.06 31.00 31.04 31.10 C-40 72.05 72.28 71.25 71.80
C-12 70.35 70.46 70.37 70.35 C-5 78.43 76.69 77.04 78.22
C-13 49.65 49.62 49.67 49.65 C-60 63.04 68.67 69.36 63.04
C-14 51.60 51.62 51.61 51.59 20-Ara(p)
C-15 30.95 60.94 30.97 30.95 10 0 e e 105.95 e
C-16 26.82 26.84 26.85 26.81 200 e e 71.68 e
C-17 51.81 51.86 51.84 51.79 300 e e 74.28 e
C-18 16.98 16.55 16.54 16.53 400 e e 68.76 e
C-19 16.47 16.55 16.54 16.50 500 e e 67.13 e
C-20 83.48 83.61 83.67 83.46 20-Ara(f)
C-21 25.95 26.02 26.03 25.94 100 e 110.28 e e
C-22 36.31 36.36 36.38 36.32 200 e 83.47 e e
C-23 23.39 23.35 23.34 23.37 300 e 79.01 e e
C-24 126.12 126.22 126.21 126.12 400 e 86.19 e e
C-25 131.09 131.23 131.31 131.07 500 e 62.84 e e
C-26 22.56 22.53 22.45 22.52
C-27 17.95 18.10 18.16 17.94
C-28 28.33 28.91 28.90 28.86
C-29 16.16 16.25 16.27 16.19
C-30 17.56 17.60 17.64 17.56
1) In this work, assignments were based on 1H, 13C, DEPT, HSQC NMR experiments and compared with [31].
J Ginseng Res 2015;39:221e229228separated using the silica-gel column to obtain the monomer gin-
senoside about 5.20  0.50 g of C-Mc, 0.96  0.17 g of C-Y,
16.3  1.5 g of F2, and 16.9  1.3 g of C-K. The theoretical yield was
approximately 43.7% for C-Mc from Rc, 42.4% for C-Y from Rb2, and
rough estimate 69.5% for F2 and C-K from Rb1 and Rd (ignoring C-K
from the Rb2 and Rc).O
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Fig. 6. The structure of minor ginseTherefore, four monomer minor ginsenosides (C-Mc, C-Y, F2,
and C-K) were successfully produced from the low-cost PPD-gin-
senosides containing ginsenoside Rb1, Rb2, Rc, and Rd using the
low-cost crude enzyme from A. niger g.848 strain. This is the ﬁrst
report on the production of fourminor ginsenosides fromAmerican
ginseng PPD-ginsenoside by enzyme.HO
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